| Literature DB >> 32878611 |
Tegenaw Tiruneh1, Teklehaimanot Kiros2, Sisay Getu2.
Abstract
BACKGROUND: Hematological reference intervals are used for medical decision tools for interpretation of numerical test results. Establishing of hematological interval among newborn babies is very important for the diagnosis of malignancy, anemia, bleeding disorders, and various infections. There are no locally established hematological reference intervals in Ethiopia. Thus, the aim of this study is to establish locally determined hematological reference interval among full-term newborns.Entities:
Keywords: Debre Tabor; Ethiopia; Hematological reference interval; newborns
Mesh:
Year: 2020 PMID: 32878611 PMCID: PMC7465431 DOI: 10.1186/s12887-020-02320-5
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Sociodemographic characteristics of study participants
| Variable | Frequency | Percentage (%) | |
|---|---|---|---|
| Gender | Male | 75 | 49.7 |
| Female | 76 | 50.3 | |
| Residence of mother | Urban | 132 | 87.4 |
| Rural | 19 | 12.6 | |
| Occupation of the mother | Employed | 54 | 35.8 |
| House wife | 57 | 64.2 | |
| Birth weight | Normal ( > = 2.5 kg) | 136 | 90.1 |
| Under birth (< 2.5 k.g) | 15 | 9.9 | |
| Gravidia | Primigravidia | 65 | 43 |
| Multigravidia | 86 | 57 | |
The influence of sex and delivery type on hematological parameter in newborns based on median value
| Hematological parameter | Sex | Delivery type | ||||
|---|---|---|---|---|---|---|
| Male | Female | Vaginal | Cesarean | |||
| WBC(x109/l) | 12.6 | 13.15 | 0.98 | 12.6 | 13.1 | 0.64 |
| RBC(x1012/l) | 4.7 | 4.6 | 0.51 | 4.61 | 4.73 | 0.27 |
| Hgb (g/dl) | 16.2 | 15.75 | 0.47 | 15.8 | 16.6 | 0.09 |
| Hct (%) | 49.6 | 48.65 | 0.44 | 48.6 | 50.45 | 0.05 |
| Platelet (x109/l) | 292 | 271 | 0.17 | 276 | 274 | 0.62 |
| Lymphocyte absolute (x109/l) | 4.5 | 4.6 | 0.12 | 4.6 | 4.55 | 0.91 |
| Neutrophil absolute ((x109/l) | 6.4 | 7.25 | 0.19 | 7 | 6.95 | 0.57 |
The reference interval and median value of all hematological parameter among full-term newborns (N = 151)
| Hematological parameter | Median (IQR) | Lower limit (2.5th ) | Upper limit (97.5th ) | RI (95th percentile) |
|---|---|---|---|---|
| Total WBC (x109/l) | 12.8 (10.5–15.4) | 7.64 | 22.16 | 7.64–22.16 |
| RBC (x1012/l) | 4.64 (4.25–4.89) | 3.69 | 5.47 | 3.69–5.47 |
| Hgb (g/dl) | 16 (14.8–17) | 13.32 | 19.64 | 13.32–19.64 |
| Hct (%) | 49.1 (44.9–51.8) | 39.42 | 58.06 | 39.42–58.06 |
| MCV (fl.) | 105.85 (102.6-109.6) | 91.6 | 113.22 | 91.6-113.22 |
| MCH (pg) | 35 (33.7–35.7) | 30.48 | 38.02 | 30.48–38.02 |
| MCHC (g/dl) | 33.1 (32.5–33.5) | 31.48 | 36.5 | 31.48–36.5 |
| Platelet (x109/l) | 276 (233–314) | 132.74 | 413.4 | 132.74–413.4 |
| Lymphocyte percentage (%) | 35.9 (30–41) | 14.22 | 58.32 | 14.22–58.32 |
| Mix percentage (%) | 10.3 (7.9–12.5) | 3.34 | 18.64 | 3.34–18.64 |
| Neutrophil percentage (%) | 53.5 (48.5–60.7) | 36.74 | 79.48 | 36.74–79.48 |
| Lymphocyte absolute (x109/l) | 4.6 (3.6–5.5) | 2.16 | 10.3 | 2.16–10.3 |
| Mix absolute (x109/l) | 1.3 (0.9–1.7) | 0.4 | 2.94 | 0.4–2.94 |
| Neutrophil absolute (x109/l) | 7 (5.4–8.9) | 2.96 | 13.54 | 2.96–13.54 |
| RDW-SD | 68.1 (64.7–72.1) | 55.48 | 81.3 | 55.48–81.3 |
| Platelet distribution width (PDW) | 11.3 (10.5–12.2) | 8.8 | 15.68 | 8.8-15.68 |
| Mean platelet volume (MPV) | 9.5 (9.1–10) | 7.88 | 11.04 | 7.88–11.04 |
Comparison of the current study to other similar findings based on cord blood hematological parameters
| Hematological | RI | |||||||
|---|---|---|---|---|---|---|---|---|
| Northwest | Saudi Arabia ( | Nepal ( | Pakistan ( | Lagos, Nigeria ( | Mashhad, Iran ( | Iraq ( | Sagamu, | |
| Total WBC | 7.64–22.16 | 10.9–21.5 | 10.49–19.4 | 9.7–17.7 | 7.9–18.3 | 5.16–18.2 | 7.32–12.92 | 4.2–25.8 |
| RBC | 3.69–5.47 | 5.1–16.3 | 3.67–4.93 | - | 3.52–4.62 | 3.61–5.29 | 3.53–4.47 | 4.3–5.9 |
| Hgb | 13.3–19.6 | 15.7–19.7 | 13.28–17.2 | 13.5–17.3 | 11.8–14.8 | 13-18.8 | 12.3-15.22 | 13-17.8 |
| Hct | 39.4–58.1 | 46.9–59.5 | - | - | 39-50.6 | 39.6–56.9 | 39.7–49.2 | 39.1–53.5 |
| MCV | 91.6-113.2 | 97.9-112.3 | 95.2-107.2 | 103.8–108 | 98.5-122.2 | 97.5-119.8 | 105.5-117.7 | 84.4–98.8 |
| MCH | 30.5-38.02 | 30.2–40.6 | 31.6–36.2 | 32.2–35.4 | 28.5–36.7 | 31.7–40 | 32.1–36.8 | 27.9–33.1 |
| MCHC | 31.48–36.5 | 27-40.2 | 31.7–34.9 | - | 28.1–31.4 | 30.1–35.2 | 29.03–32.86 | 31.7–34.5 |
| Platelet | 132.7–413 | 178.2–297 | 165.6-288.2 | 223–347 | 152.9-297.3 | 131–383 | 207–328 | 129–607 |
| Lymphocyte % | 14.2–58.3 | 16.5–37.1 | 23.7–46.7 | - | - | - | 29.6-49.98 | 27.8–49.6 |
| Neutrophil percentage | 36.7–79.5 | 50.3–74.1 | 51.5–74.7 | - | - | - | 39.8–62.2 | 45.9–67.7 |
| Lymphocyte absolute | 2.16–10.3 | - | - | 3.3–6.9 | - | 1.14–8.46 | - | - |
| Neutrophil absolute | 2.96–13.54 | - | - | 4.7–10.7 | - | 1.12–10.2 | - | - |
N =sample size